The October 15 issue of JNCI features articles on a new study design for evaluating biomarkers, the association between NSAID use and breast cancer risk, tamoxifen treatment and the detection of estrogen receptor-negative breast cancer, sorafinib to treat older patients with renal cell carcinoma, a mediator of malignant pleural effusion, and risk factors for male breast cancer.
